In summary, estrogen and ER regulate glucose metabolic pathways through different genetic targets and contribute to metabolic plasticity observed in the HR+ breast tumors enhancing tumor progression and ability to metastasize. This evidence concerns the gene ESR1 and breast neoplasm.